aTyr Pharma LIFE reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
aTyr Pharma missed estimated earnings by 15.79%, reporting an EPS of $-0.44 versus an estimate of $-0.38.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 3.06% drop in the share price the next day.
Here's a look at aTyr Pharma's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.33 | -0.28 | -0.60 | -0.51 |
EPS Actual | -0.44 | -0.31 | -0.42 | -0.64 |
Revenue Estimate | 170K | 3.02M | 230K | 620K |
Revenue Actual | 0 | 0 | 0 | 0 |
To track all earnings releases for aTyr Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.